Premium
Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome
Author(s) -
Vetro Calogero,
Rosso Rosamaria,
Palmucci Stefano,
Russello Maurizio,
Colletta Grazia,
Romeo Maria Anna,
Ximenes Benedetta,
Romano Alessandra,
Palumbo Giuseppe Alberto,
Di Raimondo Francesco
Publication year - 2016
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.21434
Subject(s) - medicine , apheresis , intensive care medicine , pediatrics , platelet
Dysmetabolic iron overload syndrome is a rare event causing hepatic impairment with serious long‐term side effects. Here, we describe a case of metabolic syndrome‐related hepatic iron overload that showed a rapid, effective, and safe response to erythrocytapheresis. J. Clin. Apheresis 31:443–447, 2016. © 2015 Wiley Periodicals, Inc.